
KREAXI
Description
KREAXI is an independent asset management firm based in Limonest, France, specializing in venture capital and development capital. With a significant presence in the Auvergne-Rhône-Alpes region for over 30 years, KREAXI has established itself as a key financial partner for innovative companies. Their core mission involves addressing capital investment shortcomings for high-potential businesses, ranging from nascent startups to more mature small and medium-sized enterprises (SMEs).
The firm's investment strategy is bifurcated into venture capital and development capital, catering to different stages of company growth. For early-stage and growth-phase companies, KREAXI's venture capital funds target seed, Series A, B, and C rounds. Within this segment, their typical first cheque sizes range from €0.5 million to €5 million, demonstrating their commitment to providing substantial initial funding to promising ventures. This approach allows them to support the scaling of innovative businesses across various sectors.
Beyond early-stage funding, KREAXI also deploys development capital for more established SMEs, facilitating operations such as management buyouts (MBOs/MBIs), external growth initiatives, and general corporate development, with larger ticket sizes up to €10 million. Over its extensive history, KREAXI has supported more than 200 companies, showcasing its deep engagement with the entrepreneurial ecosystem. The firm currently manages over €400 million in assets, underscoring its significant financial capacity and its role in fostering economic development and innovation within the French regions.
Investor Profile
KREAXI has backed more than 66 startups, with 0 new investments in the last 12 months alone. The firm has led 14 rounds, about 21% of its total and boasts 11 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in France, Switzerland, Italy.
- Strong thematic focus on Software, Health Care, Medical.
- Typical check size: $540K – $5.4M.
Stage Focus
- Seed (38%)
- Series Unknown (33%)
- Series A (18%)
- Series B (5%)
- Pre Seed (3%)
- Series E (2%)
- Series C (2%)
Country Focus
- France (97%)
- Switzerland (2%)
- Italy (2%)
Industry Focus
- Software
- Health Care
- Medical
- Information Technology
- Saas
- Manufacturing
- Electronics
- Artificial Intelligence (Ai)
- E-commerce
- Medical Device
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.